| Literature DB >> 26858642 |
Nima Samie1, Batoul Sadat Haerian2, Sekaran Muniandy3, Anita Marlina4, M S Kanthimathi5, Norbani B Abdullah4, Gholamreza Ahmadian6, Raja E R Aziddin7.
Abstract
The aim of this study was to evaluate the cytotoxic potential of a novelEntities:
Keywords: NF-κB; apoptosis; cell cycle arrest; colon cancer; nickel(II) complex
Year: 2016 PMID: 26858642 PMCID: PMC4729910 DOI: 10.3389/fphar.2015.00313
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1(A) The synthetic steps for the preparation of ligand. (B) The structural formula of L was ascertained from 1H-NMR and FTIR spectroscopies. The amide protons appear as a singlet at 7.71 ppm, and all aromatic protons appear as a multiplet in the range 7.44–7.51 ppm. (C) Ni (II) complex containing polymeric ligand was synthesized as a greenish precipitate in ethanolic solution owing to their low ethanol solubility. The complex is a dinuclear repeat unit and stable toward air and moisture. It is soluble in DMSO but insoluble in common organic solvents.
MTT cell proliferation assay for 24, 48, and 72 h on normal and cancer cells.
| 24 | 6.07 ± 0.22 | 6.26 ± 0.13 | 55.16 ± 0.07 |
| 48 | 5.87 ± 0.35 | 6.02 ± 0.02 | 53.25 ± 0.11 |
| 72 | 5.65 ± 0.11 | 5.91 ± 0.23 | 52.94 ± 0.06 |
| 24 | 1.08 ± 0.14 | 1.17 ± 0.06 | 1.33 ± 0.15 |
Figure 2NTC arrests the cell cycle in the S/M phase. Cells were incubated with DMSO (control negative) and NTC (6.0 μM) for 24 h following collection and staining with BrdU and Phopho-Histone H3. Treatment with NTC revealed no significant changes in the BrdU and Phosho-Histone H3 fluorescence intensity which suggests that the cells have not been arrested at S/M phase.
Figure 3Effect of NTC on development of cell cycle using flow cytometry. Momentous cell cycle arrest was identified at G1 phase after 24 and 48 h incubation of the cells with NTC. All data were expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.
Figure 4Immunofluorescence study of the effect of NTC. (A) After treatment of the cells with NTC (6.0 μM), Hoechst 33,342, cytochrome c, membrane permeability and mitochondrial membrane potential dyes were applied. (B) Representative bar charts indicate a dose-dependent reduction of MMP (JC-1), elevated cell permeability and cytochrome c release in treated cells. All data were expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.
Figure 5Translocation of NF-κB. After treatment of both cancer cells by several concentration of NTC for duration of 3 h, the cells were exposed for 30 min to TNF- α (1 ng/ml). Results disclosed no significant cytoplasmic to nucleus translocation of NF-κB. All data were expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.
Figure 6Time-dependent activation of caspase 3/7, 8 and 9 by NTC (6.0 μM). The results disclosed a significant activation in caspase 3/7, 8, and 9 in a time-dependent manner. All data were expressed as the means ± standard error of triplicate measurements.
Figure 7Western blot analysis of cancer and normal cell lines. Cells were treated with 3.0 and 6.0 μM of NTC for 24 h. Proteins were transferred to a membrane and followed by probing with antibodies. Normalization of band densities of treated samples were accomplished based on the control. The results represent significant increase in the expression level of caspase 3, 7, 8, 9, p53, Bax and conversion of Bid to its truncated, whereas decrease in Bcl-2 and Bcl-xL level.
Figure 8Quality assay of apoptosis. Cells were treated with EGTA/AM (25 μM) prior to exposure to NTC 6.0 μM. Apoptosis analysis shows (Left to right); the untreated cells as the control; 24 h NTC-treatment of the cells; 24 h NTC-treatment+ EGTA/AM.